ArticleThrombosis and haemostasis2024
Marginal Zone B Cells Represent a Conserved Initiating Player in the Immune Response to Factor VIII in Hemophilia A Mice.
Maya Maarouf, Seema R Patel, Wallace Hunter Baldwin, Patricia E Zerra, Courtney Cox, Ernest T Parker, Sean R Stowell, Shannon L Meeks
Abstract readLetter
In one paragraphArticle in Thrombosis and haemostasis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Maya Maarouf *Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, Georgia, United States.
Seema R Patel *Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, Georgia, United States.ORCID 0000-0002-3471-3696 Wallace Hunter BaldwinAflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, Georgia, United States.
Patricia E ZerraAflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, Georgia, United States.
Courtney CoxAflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, Georgia, United States.
Ernest T ParkerAflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, Georgia, United States.
Sean R StowellBrigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
Shannon L MeeksAflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, Georgia, United States.
Funding
Unraveling the immune response to factor VIIIU54HL141981 · NHLBI · EMORY UNIVERSITY · PI MEEKS, SHANNON L. · 2018 to 2022
$8.1MDefining Initiating Factors Responsible for the Development of FVIII InhibitorsR01HL141335 · NHLBI · EMORY UNIVERSITY · PI MEEKS, SHANNON L. · 2018 to 2022
$2.3MNHLBI NIH HHS R01 HL141335NHLBI NIH HHS U54 HL141981R01 HL141335
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
B-LymphocytesDisease Models, AnimalFactor VIIIHemophilia AAnimalsMiceMice, Inbred C57BLMice, KnockoutFactor VIII
Identifiers
PMID39013441
PMCPMC12571081
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390